Columbia University scientists study tumor revertants as possible new approach to cancer therapy.
A new targeted therapy for hard-to-treat chronic lymphocytic leukemia appears to have fewer side effects than a previous therapy.
Columbia researchers Andrea Califano and Jean Gautier have received prestigious NCI awards that support and encourage leaders in cancer research.
Columbia has one of six new sites launched by the NIH's Breast Cancer and Environment Research Program for prevention and research across the lifespan.
Dr. Andrea Califano has won a two-year $200,000 research grant for neuroendocrine cancer research.
According to a recent study, a microsurgical approach is found to be a safe and effective technique to prevent breast cancer-related lymphedema.